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At Risk for Huntington's Disease
HD is a genetically caused brain disorder that causes uncontrollable bodily movements and robs
people's ability to walk, talk, eat, and think. The final result is a slow, ugly death. Children of parents
with HD have a 50-50 chance of inheriting the disease. There is no cure or treatment.

Blog Archive
▼ 2021 (12)
► November (1)
► September (1)
► July (1)
▼ May (2)
‘Inequality is
unsustainable’: a
view of the quest...
‘The first at-bat is never
a grand slam’: how
Hunt...
► April (3)
► March (2)
► February (2)
► 2020 (16)
► 2019 (19)

SUNDAY, MAY 16, 2021

‘Inequality is unsustainable’: a view of the quest for
Huntington’s disease treatments from the Global
South
(I dedicate this article to the worldwide HD community as we
mark Huntington’s Disease Awareness Month in many countries
around the planet.)
Both the COVID-19 pandemic and the quest for treatments for
rare and genetic diseases have laid bare deep social divisions
across the world, and it behooves the scientific establishment to
help resolve this ethical dilemma, says a leading Brazilian
Huntington’s disease clinician.
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“The world should not be divided between those who have money
and those who don’t,” Mônica Santoro Haddad, M.D., a
neurologist with 33 years’ practice at the Universidade de São
Paulo (USP) School of Medicine, told me in an April 30 Zoom
interview about the 16th Annual HD Therapeutics Conference.
“The pandemic has already shown us that. This inequality is
unsustainable.”

► 2007 (7)
► 2006 (4)

Dr. Haddad has assisted HD patients from 600 families at the USP
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neurology clinic and her private office. A participant in the 2013
Therapeutics Conference in Venice, Italy, and 2014 meeting in
Palm Springs, CA, she watched all of this year’s three-day virtual
event (April 27-29) online. The conferences are sponsored by
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“What we’re witnessing in Brazil [regarding the pandemic] is
immoral – Brazil in relationship to the world and Brazil in
general,” Dr. Haddad observed, speaking in her native Portuguese.
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“Two categories of people have been created: those with the
vaccine, those without the vaccine.”
A South American giant struggles
Sadly, Brazil ranks second in the world behind the United States
with more than 428,000 COVID-19 deaths.
As a history professor, I have dedicated much of my career to the
study of Brazil, a country that I consider my second home; my
wife is Brazilian, and her extended family is there. Along the way,
I have witnessed the development of the Associação Brasil
Huntington and built ties to its leaders.
A major country of the Global South – the world’s developing
countries – Brazil has an estimated 20,000-plus afflicted
individuals and an active HD movement. An enthusiastic group of
some 30 Brazilians took part in #HDdennomore, Pope Francis’
special audience with the HD in May 2017. Francis, a native of
Argentina, is also the first pontiff from the Global South.
However, although Brazil’s medical system has gained
international recognition for past vaccine campaigns and its model
fight against AIDS, during the pandemic the country has lacked
hospital beds, cemetery plots, and basic supplies. Like Donald
Trump, Brazilian President Jair Bolsonaro denied the crisis,
downplayed the dangers, and actively denounced such measures as
mask-wearing.
In addition, Brazil has fallen victim to the international inequities
in the rollout of vaccines. Both U.S. President Joe Biden and
former Brazilian president Luiz Inácio Lula da Silva – a likely
candidate in the 2022 presidential election – have backed waiving
COVID-19 vaccine patents to assure global access.
Brazil’s deep internal disparities have led to inadequate vaccine
distribution to the poor and marginalized.
Recognizing similar, longstanding neglect in other South
American countries, the humanitarian organization Factor-H has

curehd.blogspot.com/2021/05/inequality-is-unsustainable-view-of.html

2/9

11/23/21, 9:40 AM

At Risk for Huntington's Disease: ‘Inequality is unsustainable’: a view of the quest for Huntington’s disease treatments from the G…

continued to assist abandoned HD families during the crisis.
Providing everybody access to medicines
Echoing her concerns about COVID-19, Dr. Haddad affirmed the
need for a “change in the paradigm” regarding rare and genetic
diseases like Huntington’s.
As in the U.S. and elsewhere, fear and denial frequently underlie
Brazilians’ decisions to avoid genetic testing and facing the
terrible medical and social challenges posed by the disease. Many
Brazilians have “prejudice against disease” in general, Dr. Haddad
told me in a 2013 interview.
However, the trend against testing might be shifting for the
younger generations, and could also change among older groups
when the overall outlook for treatments has improved, Dr. Haddad
wrote in a May 14 WhatsApp message. Clinical trials seeking
presymptomatic HD gene carriers will require testing, she added.
Like medical professionals in many countries, Dr. Haddad believes
genetic testing is a personal decision, with the procedure governed
by established protocol and with professional medical and
psychological support.
As of April 2021, the Brazilian government has required all private
health plans and insurance to cover genetic testing. This
represented a “small advance,” Dr. Haddad asserted in our Zoom
interview, because health advocates want to see the country’s free
public health service also provide that benefit.
For Dr. Haddad, for HD to be defeated, inequality must diminish.
“The question is: is it ethical to diagnose someone with one of
those diseases and not have a treatment available?” Dr. Haddad
said. “This is a question that I discuss with my patients and with
my colleagues.”
She added: “It is certainly not ethical to have a treatment that not
everybody has access to.”
curehd.blogspot.com/2021/05/inequality-is-unsustainable-view-of.html
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The HD Therapeutics Conference left her with her “hope battery
recharged” and confident that a treatment is possible, Dr. Haddad
said.

Gene Veritas interviewing Dr. Mônica Haddad (screenshot by
Gene Veritas, aka Kenneth P. Serbin)
Advocating for open science
At the close of the conference, Dr. Haddad was inspired by the
presentation by featured speaker Aled Edwards, Ph.D., who in
2004 founded the Structural Genomix Consortium (SGC), which
practices and advocates for open sharing of scientific information,
particularly as it applies to protein science, chemical biology, and
drug discovery.
Dr. Edwards, the SGC CEO and a scientist based at the University
of Toronto, spoke on “HD drug discovery in the public domain – a
model for CHDI.” A breath of “fresh air,” Dr. Edwards’ talk
pointed the way to reducing inequality, Dr. Haddad told me.
“What we would also like to do is develop a drug discovery
ecosystem that prioritizes affordability and global access, and, of
course, to do this in collaboration with industry,” Dr. Edwards
stated. “Now this might sound naïve, but I’d like to emphasize
there’s quite a bit of drug discovery experience in the SGC and in
our network.”
Dr. Edwards presented examples of researchers who have followed
the open science model – including 16 “HD open science
programs” that share science “as they go,” with some even
blogging about their findings. He highlighted the work of Rachel
Harding, Ph.D., an SGC researcher and postdoctoral fellow at the
curehd.blogspot.com/2021/05/inequality-is-unsustainable-view-of.html
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University of Toronto who achieved the “very challenging” task of
purifying the huntingtin protein to a “resolution that is practically
useful” to other scientists.
Dr. Harding has widely shared both the protein and reagents
(compounds that facilitate chemical reactions) that enable the
making of the protein, ultimately aiming to inform the discovery
of potential HD drugs, in particular so-called small-molecule
drugs, Dr. Edwards explained.
Discussed at the Therapeutics Conference, these drugs become
distributed very evenly across the whole body, including the brain,
whereas several drugs in other current or recently completed
clinical trials need to be injected directly into the brain or via
spinal tap.
“This is a really fantastic contribution to the public good that these
folks have made,” Dr. Edwards said of Dr. Harding’s team.

Sharing science as they go: Huntington's disease "open science champs"
as presented by Dr. Aled Edwards, at upper right (screenshot by Gene
Veritas)

Seeking more efficient drug discovery
Dr. Edwards underscored a key point: despite spending $300
billion globally each year on research and development and
producing many hugely successful drugs, the biomedical field is
highly inefficient. “We need to do better as a society,” he asserted.
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“For many diseases – Huntington’s, Parkinson’s, Alzheimer’s – we
don’t even know the molecular mechanism of the disease, let alone
how to design a therapeutic strategy,” Dr. Edwards said, adding
that a system in which the “first past the post gets the money” in
designing drugs has required “the pricing of medicines at levels
that are unaffordable for most people on the planet.”
Dr. Edwards displayed data demonstrating how globally most
research focuses on the familiar rather than explore new,
potentially crucial areas of biology. Similarly, in industry,
companies pursue drugs in parallel rather than collaborate, wasting
valuable resources, he added.
SGC is working against the grain, trying to create the way for a
new scientific culture. The SGC never files for patents “as a core
principle,” Dr. Edwards explained. “All of the work we do goes
into the public domain, including the reagents that we make.”
If labs and companies openly shared data before doing the final
crucial test on a potential drug in a Phase 3 trial, the field could not
only save money, but test multiple drugs at the same time, he said.
Rather than rely on patents, the system should take advantage of
federal laws that give companies protection from competition for a
fixed period, generally five to twelve years, Dr. Edwards affirmed.
The law provides even longer periods for orphan and pediatric
drugs.
Supporting the public good
“There is no law of physics that says industry has to invent a
drug,” Dr. Edwards said. “That’s the social system that we’ve put
in place. Let’s imagine a different system.”
To “walk the walk about open drug discovery,” SGC established
the Agora Open Science Trust, a registered charity in Canada
modeled on Newman’s Own Foundation, which funnels profits
from food products with the picture of the late Academy-AwardWinning actor into philanthropy.
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Dr. Edwards described its goal: “To support open science and the
public good, and price new medicines to ensure global access.
Whether you’re a rich American or live in Thailand, you’re going
to get the medicine at a price you can afford.”
In its first project, Agora has focused on children’s cancers. As of
yet the trust has not announced a plan for an HD drug program,
although Dr. Edwards and the above-mentioned HD open science
researchers have an abiding interest in finding treatments.
Indeed, regarding those treatments, Dr. Edwards concluded that “if
we do it as a collective, we’ll get further faster.”

Dr. Aled Edwards explains the creation of for-profit drug
companies to fund the Agora Open Science Trust, whose mission is
to ensure global, affordable access to new medicines (screenshot
by Gene Veritas).
Knowledge belongs to the world
If Dr. Edwards and SGC achieve their goals, they will have a place
in history, Dr. Haddad observed. The emphasis on sharing data
will “democratize” knowledge, she added.
“It’s obvious that a company does things to earn money,” Dr.
Haddad continued. She noted, however, that Dr. Edwards is asking
scientists and others to put their vanity aside to help the suffering.
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Brazil has not yet hosted, and may not host in the future, any sites
for the major HD clinical trials, Dr. Haddad pointed out. She noted
that the local HD community attempted to bring to Brazil the
historic Phase 3 gene silencing clinical trial by Roche, which
reported the unfavorable results at the HD Therapeutics
Conference. In South America, Roche ran the trial in Argentina
and Chile.
“We did the paperwork to try to include a Brazilian research
center, and because of questions raised by an ethics committee and
political and legal issues, we were unsuccessful,” Dr. Haddad
explained. “Brazil did not permit genetic material [from the
clinical trial] to be sent out of the country.”
For now, Dr. Haddad said, Brazilians can at least look forward to
the possibility of their government’s authorization of the drug
Austedo, approved by the U.S. Food and Drug Administration in
2017 for chorea, the involuntary movements that occur in many
HD-affected individuals.
At this time, Brazil’s lack of participation in clinical trials of drugs
that aim to slow or stop the disease is “not important,” Dr. Haddad
concluded. Echoing Dr. Edwards – and the hope of thousands of
Brazilian HD families anxiously awaiting the arrival of effective
treatments but fearful that the country might not be able to afford
them – she added: “The knowledge obtained belongs to the
world.”
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